Lower skeletal muscle index and early complications in patients undergoing radical cystectomy for bladder cancer

World Journal of Surgical Oncology

Dingwei Ye¹  Jingyi Cheng²  Hailiang Zhang¹  Shilin Zhang¹  Bo Dai¹  Yijun Shen¹  Xudong Yao¹  Chengyuan Gu¹  Yao Zhu¹  Fangning Wan¹ 

[1] Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China;Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China

关键词: Sarcopenia;    Postoperative complications;    SMI;    Radical cystectomy;    Bladder cancer;   

Others  :  820541
DOI  :  10.1186/1477-7819-12-14

 received in 2013-08-05, accepted in 2014-01-03,  发布年份 2014

【 摘 要 】

Background

Radical cystectomy (RC) is the standard treatment for patients with muscle-invasive bladder cancer (BC), and it is also a valid option for selected patients with high-risk non-muscle-invasive BC. The purpose of this study was to evaluate the effect on the lower skeletal muscle index (SMI) of short-term postoperative complications of radical cystectomy (RC) in patients with bladder cancer (BC).

Methods

A total of 247 patients who received RC for BC and 204 age-matched healthy population-based controls were retrospectively assessed. SMI was measured by preoperative computed tomography scans at the L4 to L5 level. Early complications were graded by Clavien-Dindo classification; severity of grade III or greater was identified as a severe complication. Logistic regression was utilized to determine the relationships between covariables and severe complications.

Results

A total of 125 (50.61%)/19 (7.69%) patients exhibited overall/severe complications during the early postoperative period. SMI was strongly associated with gender (P <0.01), but not age and body mass index (BMI), among patients with BC. Compared with the matched control group, BC patients exhibited lower SMI. The difference was statistically significant in the subgroup of male patients (P = 0.03). In the multivariate analysis, SMI was an independent predictor of developing severe complications. Each 1 cm²/m² increase in SMI was associated with a decrease in the odds of morbidity by 4.8%.

Conclusions

A lower SMI is frequently observed in bladder cancer patients undergoing RC and is shown to be strongly associated with early complications following surgery.

【 授权许可】

   
2014 Wan et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Lee JS, Auyeung TW, Kwok T, Lau EM, Leung PC, Woo J: Associated factors and health impact of sarcopenia in older chinese men and women: a cross-sectional study. Gerontology 2007, 53:404-410.
• [2]Shabsigh A, Korets R, Vora KC, Brooks CM, Cronin AM, Savage C, Raj G, Bochner BH, Dalbagni G, Herr HW, Donat SM: Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 2009, 55:164-174.
• [3]Svatek RS, Fisher MB, Matin SF, Kamat AM, Grossman HB, Nogueras-Gonzalez GM, Urbauer DL, Kennedy KA, Dinney CP: Risk factor analysis in a contemporary cystectomy cohort using standardized reporting methodology and adverse event criteria. J Urol 2010, 183:929-934.
• [4]Wen X, Wang M, Jiang CM, Zhang YM: Are current definitions of sarcopenia applicable for older Chinese adults? J Nutr Health Aging 2011, 15:847-851.
• [5]Coward RM, Smith A, Raynor M, Nielsen M, Wallen EM, Pruthi RS: Feasibility and outcomes of robotic-assisted laparoscopic radical cystectomy for bladder cancer in older patients. Urology 2011, 77:1111-1114.
• [6]Zhou JQ, Zhu Y, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL, Shen YJ: A nomogram to predict the duration of drainage in patients with penile cancer treated with inguinal lymph node Dissection. J Urol 2012, 187:129-133.
• [7]Donat SM, Siegrist T, Cronin A, Savage C, Milowsky MI, Herr HW: Radical cystectomy in octogenarians-does morbidity outweigh the potential survival benefits? J Urol 2010, 183:2171-2177.
• [8]Froehner M, Brausi MA, Herr HW, Muto G, Studer UE: Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol 2009, 56:443-454.
• [9]Makary MA, Segev DL, Pronovost PJ, Syin D, Bandeen-Roche K, Patel P, Takenaga R, Devgan L, Holzmueller CG, Tian J, Fried LP: Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg 2010, 210:901-908.
• [10]Osuna-Pozo CM, Serra-Rexach JA, Vina J, Gomez-Cabrera MD, Salva A, Ruiz D, Masanes F, Lopez-Soto A, Formiga F, Cuesta F, Cruz-Jentoft A: Prevalence of sarcopenia in geriatric outpatients and nursing homes. The ELLI study. Rev Esp Geriatr Gerontolin press
• [11]Safer U, Gariballa S, Alessa A: Response to letter to the editor: accurate diagnosis of sarcopenia in elderly requires correct measurement of muscle mass. Clin Nutr 2013, 32:663.
• [12]Safer U, Tasci I, Safer VB, Doruk H: Accurate diagnosis of sarcopenia in the elderly requires correct measurement of muscle mass. Clin Nutr 2013, 32:663.
• [13]Skinner DG: Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol 1982, 128:34-36.
• [14]Montero-Fernandez N, Serra-Rexach JA: Role of exercise on sarcopenia in the elderly. Eur J Phys Rehabil Med 2013, 49:131-143.
• [15]Invernizzi M, Cisari C: Sarcopenia and muscular modifications in disabling pathologies of the elderly from the physical and rehabilitation medicine: point of view. Eur J Phys Rehabil Med 2013, 49:107-109.
• [16]Lin CC, Lin WY, Meng NH, Li CI, Liu CS, Lin CH, Chang CK, Lee YD, Lee CC, Li TC: Sarcopenia prevalence and associated factors in an elderly Taiwanese metropolitan population. J Am Geriatr Soc 2013, 61:459-462.
• [17]Anker MS, von Haehling S, Springer J, Banach M, Anker SD: Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology. Arch Med Sci 2013, 9:166-171.
• [18]Miyakoshi N, Hongo M, Mizutani Y, Shimada Y: Prevalence of sarcopenia in Japanese women with osteopenia and osteoporosis. J Bone Miner Metab 2013, 31:556-561.
• [19]Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE: A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 2008, 33:997-1006.
• [20]Shen W, Punyanitya M, Wang Z, Gallagher D, St-Onge MP, Albu J, Heymsfield SB, Heshka S: Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol 2004, 97:2333-2338.
• [21]Lawrentschuk N, Colombo R, Hakenberg OW, Lerner SP, Mansson W, Sagalowsky A, Wirth MP: Prevention and management of complications following radical cystectomy for bladder cancer. Eur Urol 2010, 57:983-1001.
• [22]Esposito A, Campana L, Palmisano A, De Cobelli F, Canu T, Santarella F, Colantoni C, Monno A, Vezzoli M, Pezzetti G, Manfredi AA, Rovere-Querini P, Del Maschio A: Magnetic resonance imaging at 7T reveals common events in age-related sarcopenia and in the homeostatic response to muscle sterile injury. PLoS One 2013, 8:e59308.
• [23]Maffezzini M, Campodonico F, Capponi G, Manuputty E, Gerbi G: Fast-track surgery and technical nuances to reduce complications after radical cystectomy and intestinal urinary diversion with the modified Indiana pouch. Surg Oncol 2012, 1:191-195.
• [24]Stein JP, Skinner DG: Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure. World J Urol 2006, 24:296-304.
• [25]Peng PD, van Vledder MG, Tsai S, de Jong MC, Makary M, Ng J, Edil BH, Wolfgang CL, Schulick RD, Choti MA, Kamel I, Pawlik TM: Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB (Oxford) 2011, 13:439-446.
• [26]Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD: Cachexia: a new definition. Clin Nutr 2008, 27:793-799.
• [27]Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Biolo G, Boirie Y, Bosaeus I, Cederholm T, Costelli P, Fearon KC, Laviano A, Maggio M, Rossi Fanelli F, Schneider SM, Schols A, Sieber CC: Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 2010, 29:154-159.
• [28]Argiles JM, Busquets S, Lopez-Soriano FJ, Figueras M: Physiology of sarcopenia. Similarities and differences with neoplasic cachexia (muscle impairments in cancer and ageing). Nutr Hosp 2006, 21(Suppl 3):38-45.
• [29]Polterauer S, Zhou Q, Grimm C, Seebacher V, Reinthaller A, Hofstetter G, Concin N, Leitao MM Jr, Barakat RR, Abu-Rustum NR, Iasonos A: External validation of a nomogram predicting overall survival of patients diagnosed with endometrial cancer. Gynecol Oncol 2012, 125:526-530.
• [30]Thomas DR: Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr 2007, 26:389-399.
• [31]Ogawa S, Ouchi Y: Aging and bio-motor function. Approaches to sarcopenia. Clin Calcium 2013, 23:93-98.
• [32]van Abellan KG, Cesari M, Gillette-Guyonnet S, Dupuy C, Nourhashemi F, Schott AM, Beauchet O, Annweiler C, Vellas B, Rolland Y: Sarcopenia and cognitive impairment in elderly women: results from the EPIDOS cohort. Age Ageing 2013, 42:196-202.
• [33]Hunkyung K: Comprehensive interventions for the prevention of sarcopenia. Nihon Ronen Igakkai Zasshi 2012, 49:206-209.
• [34]Jeejeebhoy KN: Malnutrition, fatigue, frailty, vulnerability, sarcopenia and cachexia: overlap of clinical features. Curr Opin Clin Nutr Metab Care 2012, 15:213-219.
• [35]Sugimoto K: The role of mitochondrial function in skeletal muscle and myokines in the pathogenesis of sarcopenia. Nihon Ronen Igakkai Zasshi 2012, 49:199-202.
• [36]Malafarina V, Uriz-Otano F, Iniesta R, Gil-Guerrero L: Effectiveness of nutritional supplementation on muscle mass in treatment of sarcopenia in old age: a systematic review. J Am Med Dir Assoc 2013, 14:10-17.
• [37]Sanada K, Miyachi M, Tanimoto M, Yamamoto K, Murakami H, Okumura S, Gando Y, Suzuki K, Tabata I, Higuchi M: A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors. Eur J Appl Physiol 2010, 110:57-65.
• [38]Kim TN, Park MS, Yang SJ, Yoo HJ, Kang HJ, Song W, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM: Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Care 2010, 33:1497-1499.